Navigation Links
Mayor Antonio Villaraigosa Partners With AltaMed Health Services to Launch City of Los Angeles HIV Testing Initiative
Date:11/30/2007

Initiative to Focus on Testing 1 Million Angelenos Within Three Years

LOS ANGELES, Nov. 30 /PRNewswire/ -- AltaMed Health Services played host to Mayor Antonio Villaraigosa today as he launched the City of Los Angeles HIV Testing Initiative, which seeks to test 1 million Angelenos within the next three years. The Mayor tested for HIV at AltaMed's Medical and Dental group in the Ramona Gardens community to underscore the importance of "early testing" within the Latino community.

A study conducted by the California Department of Health Office of AIDS indicates the number of Latinos with AIDS increased nearly 128% between 1996 and 2006. This is due in part to a disturbing trend that indicates Latinos are "late testers" often diagnosed with HIV six months to one-year before they contract AIDS. AIDS is the leading cause of death for male Latinos ages 22-44 and the second cause of death for Latinas in the same age group. Early detection is critical to ensure HIV patients have access to medical treatment that can improve their chances of leading long and healthy lives.

"We commend the Mayor for his leadership on this issue and are proud to support his effort to make HIV testing and counseling more routine and accessible," said Castulo de la Rocha, president and CEO of AltaMed Health Services. "AltaMed is at the forefront of providing culturally appropriate HIV/AIDS care and services to Latinos. Together with our community partners, the Latino Coalition Against AIDS, and the City of Los Angeles, we are fully committed to expanded testing, to getting Latinos diagnosed earlier and to connecting them with the necessary care and treatment."

The AltaMed HIV Mobile Testing Unit (MTU) was on hand to administer free HIV tests to the community of Ramona Gardens. The MTU is just one of many services offered by AltaMed specifically tailored for the Latino community that include mental health, medical treatment, the AIDS Drug Assistance Program, access
'/>"/>

SOURCE AltaMed Health Services Corporation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. AIDS Healthcare Foundation Applauds City Commissioners Support of Diversity, Urges Call for Mayors Resignation
2. Mayors Express Frustration Over President Bushs Veto to SCHIP Legislation
3. Mayors Office Declares October 13 as First Metastatic Breast Cancer Awareness Day for New York City
4. Uncontrolled Blood Pressure Highest Among Hispanics, Prompting New Hypertension Project in San Antonio
5. October 18 Rally - San Antonio - to Protest Attack on Medical Benefits By AT&T Corporation
6. Pelosi, Members of Texas Delegation to Rally for Childrens Health Care in San Antonio Tomorrow
7. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
8. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
9. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
10. Thailand: Partners Open Free AIDS Treatment Clinic in Renowned AIDS Temple in Lop Buri
11. AtriCure to Present at Roth Capital Partners 2007 New York Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...ert Pathologists Discuss the Latest Developments i...RTHFIELD, Ill., Sept. 5 /PRNewswire-USNewswire/ --...point. Molecular testing and the promise,of person...reated. Digital,slides and other imaging technolog...lege of American Pathologists is taking a leadersh...
(Date:9/5/2008)...hers explain how theoretical ,anti-cloak, could br...pt. 5 (HealthDay News) -- Just in case someone dev...cientists say they know how to uncloak the objects... Optics Express , certain materials underneath an ...o be seen again. , Researchers at Shanghai Jiao...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- Speake...y in support of the aims of the "Stand,Up to Cance... "There is not a person in our country who has no...r kills 565,000 Americans annually, and each,year ...ricans must work,together to make eradicating the ...
(Date:9/5/2008)...HINGTON, Sept. 5 /PRNewswire-USNewswire/ -- U.S. c...r relief to Cuban victims of Hurricane,Gustav, whi...s., (http://www.PanAmericanRelief.org ), "Donatio...perately need,after this natural disaster," says M... Initiative at the Pan American Development Founda...
Breaking Medicine News(10 mins):Health News:Leaders in Pathology Meet in San Diego: Sept. 25 - 28, 2008 2Health News:Cuban Disaster Relief Donations Sought in the Wake of Hurricane Gustav 2
...ogs have surprised researchers by showing that the...an toddlers. The study, by Austrian researchers,... when it comes to a physical problem-solving test....en researchers first observed how several children...
...tgrave, PhD, an expert on HIV prevention at the Jo...argeted campaign of testing and counseling aimed ...e effective than the mass patient screening propos...and Prevention (CDC). Holtgraves study is the fir...
...nday against South Korea's hard-drinking culture w...d economic losses, officials said . The campaign f...re to enhance public awareness of the dangers of e...ealth and Welfare said. "South Koreans consider o...
...heimer drug in the form of a milkshake. This milks...tarved by the damages of the Alzheimer disease . I...g large scale testing against the brain destroying...d Ketasyn, is a new approach to treating dementia....
Other Medicine News:Health News:Dogs Reasoning on Par With Human Toddlers: Study 2Health News:Targeted HIV Testing An Effective Way to Screen HIV Patients 2Health News:A Milky Alternative to Alzheimer Drug 2
(Date:9/3/2008)...ber is National Vascular Disease Awareness Month, ...fusion Pharmaceuticals,LLC, a clinical-stage drug-...the treatment of unmet medical needs, announced to...e I/II clinical trial of its lead drug,candidate t...ed NCT00725881,on the clinicaltrials.gov Website, ...
(Date:9/3/2008)... Md., Sept. 3 /- Panacea Pharmaceutic...ent Number 7,413,737 covering,antibodies against h...), a,proprietary human cancer biomarker and therap...ollaboration with the Massachusetts Institute of,T...de rights to this patent,for development of human ...
(Date:9/3/2008)...Company to Discuss Phase 3 Plans with FDA, PRINCE...ics, Inc.,announced today that it successfully co... of the company,s new, innovative low-dose, once-w...rs to by its internal product,code AG-200-15. The ...t its,primary endpoint of ovulation suppression, c...
(Date:9/3/2008)...rial Reconfirms Strong Evidence Pycnogenol(R) Lowe...ect on Joints Following Cessation ...3 /- According to the Center for,Dise... type of arthritis,is on the rise. A new study pu...arch, reveals Pycnogenol(R), bark extract from the...
Breaking Medicine Technology:Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 2Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 3Diffusion Pharmaceuticals Announces Initiation of a Phase I/II Clinical Trial in Patients with Peripheral Arterial Disease (PAD) 4Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 2Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 3Panacea Pharmaceuticals Announces Issuance of a U.S. Patent Covering Anti-HAAH Antibodies 4Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 2Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 3Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch 4Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 2Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 3Study Shows Pine Bark Naturally Reduces Knee Osteoarthritis 4Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 1Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 2Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 3Stimuvax 28R 29 Phase II data highlight three year survival results for patients with non small cell lung cancer 376 4Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 1Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 2Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 3Cardicas C Port 28R 29 Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed Chest Heart Bypass Surgeries 371 4R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 1R P Simmons Family Foundation Pledges 242 Million for New Childrens Hospital of Pittsburgh of UPMC Campus 530 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 1Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 2Medarex Announces Extension of Broad Antibody Development Relationship with Centocor 369 3
...Lymphoma Reported,Today at ASCO Annual Meeting, PH...thKline plc,announced today long-term efficacy dat...e of frontline treatment with the BEXXAR(R),Therap...momab) in,76 patients with newly diagnosed advance...gimen was found to induce durable clinical,and mol...
...e/ -- (SEND2PRESS,NEWSWIRE) -- Epeius Biotechnolog... a historic landmark in medical oncology and a,def...gene therapy.,The first clinical report of its kin...ue of the International Journal of,Oncology, Vol.3...res of tumor destruction observed in chemo-resista...
Other Medicine Technology:8-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 28-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 38-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 48-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 58-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 68-Year Long-term Data Demonstrate Prolonged Overall Survival and,Length of Disease Remission with Bexxar 7News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 2News from the Battlefield of Metastatic Cancer: Epeius,Biotechnologies Draws the Sword of Targeted Gene Delivery (Rexin-G),from the Stone of Chemistry and Physics 3
Tank Blotting System. Designed for Western, Northern, or Southern Blotting. Transfer up to three gels with dimensions as large as 15cm x 21.5cm. Includes and internal cooling base for temperature
... proven electrophoretic transfer apparatus incorpo...ltimate in field uniformity. Its design allows for... when coupled with a low voltage power source such...ts/cm. The result is exceptionally rapid and exact...
...lot cell, a component of Bio-Rad's modular mini el...resis Systems), provides rapid, high-quality blott...ransfers two 7.5 x 10 cm gels in just 1 hour. Cool... absorbs heat generated during transfers. The Mini...
Includes PowerPac 200 power supply. Flexibility for a Range of Parameters. Quantitative Transfers. Native Enzyme, High Intensity, or Overnight Transfers. Faster, Higher-Efficiency Transfers via Pl
Medicine Products: